WHO ICTRP trial

An open-label, escalating dose, proof of concept study to determine the effects…

ISRCTN81647490 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting

Key facts

Trial ID ISRCTN81647490
Public title An open-label, escalating dose, proof of concept study to determine the effects of single oral doses of PSD506 on unstable urinary bladder contractions induced by volume provocation in subjects with detrusor hyper-reflexia secondary to spinal injuries above T12
Scientific title An open-label, escalating dose, proof of concept study to determine the effects of single oral doses of PSD506 on unstable urinary bladder contractions induced by volume provocation in subjects with detrusor hyper-reflexia secondary to spinal injuries above T12
Primary sponsor Plethora Solutions Ltd (UK)
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Specified
Countries United Kingdom
Conditions Detrusor hyper-reflexia secondary to spinal injury (mid-thoracic or cervical level) Urological and Genital Diseases Detrusor hyper-reflexia
Interventions Single oral administration of PSD506 capsules 5 mg to 40 mg
Registration date Apr 20, 2007
Target size 18
Secondary IDs PSD506-OAB-002
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations